Neuronetics (STIM) Revenue (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.53% |
| Dec 31, 2025 | 12.01% |
| Sep 30, 2025 | -2.13% |
| Jun 30, 2025 | 19.18% |
| Mar 31, 2025 | 42.16% |
| Dec 31, 2024 | 21.39% |
| Sep 30, 2024 | 12.64% |
| Jun 30, 2024 | -5.55% |
| Mar 31, 2024 | -14.26% |
| Dec 31, 2023 | 13.59% |
| Sep 30, 2023 | 1.56% |
| Jun 30, 2023 | 13.32% |
| Mar 31, 2023 | -14.61% |
| Dec 31, 2022 | 10.30% |
| Sep 30, 2022 | 1.03% |
| Jun 30, 2022 | 15.15% |
| Mar 31, 2022 | -5.60% |
| Dec 31, 2021 | 8.86% |
| Sep 30, 2021 | -2.84% |
| Jun 30, 2021 | 15.58% |
| Mar 31, 2021 | -21.12% |
| Dec 31, 2020 | 25.15% |
| Sep 30, 2020 | 27.79% |
| Jun 30, 2020 | -15.12% |
| Mar 31, 2020 | -33.88% |
| Dec 31, 2019 | 8.48% |
| Sep 30, 2019 | -3.45% |
| Jun 30, 2019 | 30.20% |
| Mar 31, 2019 | -18.59% |
| Dec 31, 2018 | 13.82% |
| Sep 30, 2018 | 3.66% |
| Jun 30, 2018 | 30.54% |
| Mar 31, 2018 | -16.15% |
| Dec 31, 2017 | 15.41% |
| Sep 30, 2017 | 1.78% |
| Jun 30, 2017 | 36.97% |